Hema Pharmaceuticals Pvt Ltd, a active private limited company, was established on 11 April 1988 in Ankleshwar, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230GJ1988PTC010557. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹6.98 M.
It upholds a compliant status. Employing 66 professional, Its leadership includes Jigneshkumar Chhaganbhai Chodvadiya (Director), Manishbhai Vrajlal Thumar (Director). Past directors included Ishwarbhai Rugnathaji Mali, Meenaben Jagdishchandra Patel, Minesh Natwarlal Modi. It holds ₹9.99 Cr open charges and ₹4.64 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6201/A Gidc, Ankleshwar, Gujarat, 393002.
U24230GJ1988PTC010557
010557
11 April 1988
₹7.00 M
₹6.98 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Hema Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jigneshkumar Chhaganbhai Chodvadiya | Director | 31 Jul 2015 | Current |
| Manishbhai Vrajlal Thumar | Director | 22 Oct 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Oct 2012 | Past |
| Pramod Abcsdd | Director | 25 Jan 2012 | Past |
| Pramod Abcsdd | Director | 05 Sep 2012 | Past |
| Pramod Abcsdd | Director | 31 Aug 2011 | Past |
| Pramod Abcsdd | Director | 22 Oct 2012 | Past |
| Pramod Abcsdd | Director | 31 Jul 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hema Pharmaceuticals Pvt Ltd, for the financial year ended 2024, experienced significant reduction in revenue, with a 14.1% decrease. The company also saw a substantial fall in profitability, with a 28.63% decrease in profit. The company's net worth moved up by a moderate rise of 9.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Hema Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹99,900,000.00
₹46,383,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2016 | Hdfc Bank Limited | ₹9.99 Cr | Open |
| 12 Mar 2013 | Bank Of Baroda | ₹4.37 Cr | Satisfied |
| 21 Oct 1989 | Gujarat Staste Financial Corporation | ₹2.68 M | Satisfied |
Explore comprehensive loan charge details -
Hema Pharmaceuticals has a workforce of 66 employees as of Sep 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hema Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hema Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 99.90 M registered on 29 Jun 2016 with Charge ID 100038729 was modified on 21 Mar 2025. was completed.
The activity Hema Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Hema Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on A charge registered on 12 Mar 2013 via Charge ID 10413347 with Bank Of Baroda was fully satisfied on 13 Jul 2016. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 99.90 M with Charge ID 100038729 was registered on 29 Jun 2016. was recorded as a recent event.
Jigneshkumar Chhaganbhai Chodvadiya was appointed as a Director was appointed as a Director on 31 Jul 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.
The CIN of Hema Pharmaceuticals Pvt Ltd is U24230GJ1988PTC010557.
Hema Pharmaceuticals Pvt Ltd is headquartered at 6201/A Gidc, Ankleshwar, Gujarat, 393002.
Hema Pharmaceuticals Pvt Ltd was incorporated on 11 April 1988.
The current directors of Hema Pharmaceuticals Pvt Ltd are
The primary industry of Hema Pharmaceuticals Pvt Ltd is Manufacturing.
Hema Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Hema Pharmaceuticals Pvt Ltd is ₹7.00 M, and the paid-up capital is ₹6.98 M.
The compliance status of Hema Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX